AR and neoplasm: Testosterone and its 5α-reduced metabolite, dihydrotestosterone (DHT), bind to the androgen receptor (AR), a ligand-dependent nuclear transcription factor, causing tumor growth and increased expression of prostate-specific antigen (PSA), among other functions [9].